Children, Adolescents and Young Adults with Myeloproliferative Neoplasia: Study of Clinico-biological Characteristics and Complications (VYP)

Last updated: December 3, 2024
Sponsor: University Hospital, Brest
Overall Status: Active - Recruiting

Phase

N/A

Condition

Leukemia

Red Blood Cell Disorders

White Cell Disorders

Treatment

N/A

Clinical Study ID

NCT06715267
29BRC23.0018 - VYP
  • Ages < 30
  • All Genders

Study Summary

The creation of a national database will provide access to solid data on the diagnosis of myeloproliferative neoplasia for patients under 30, giving a true picture of their care. It will also make it possible to identify the biological samples (histological and molecular) available in routine laboratories, enabling teams of researchers and anatomopathologists to (re)perform certain analyses to re-evaluate diagnoses and search for hitherto unknown molecular prognostic factors.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patient diagnosed with non-LMC MPN before the age of 30 (PV or TE or MFP or PreMF)according to the 2016 WHO criteria.

  • Signature of the consent form for participation in the FIMBANK project.

  • Agreement to participate in the VYP study.

  • Patient of legal age at the time of inclusion in VYP.

  • Patient affiliated to a social security scheme

Exclusion

Exclusion Criteria:

  • Refusal to participate by patients of full age

  • Patient under legal protection (guardianship, curatorship, etc.)

Study Design

Total Participants: 200
Study Start date:
April 01, 2023
Estimated Completion Date:
April 01, 2038

Connect with a study center

  • CHU de Brest

    Brest, 29609
    France

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.